Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcohol Associated Liver Disease”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableLooking for participantsNCT07525258
What this trial is testing

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

Who this might be right for
Alcohol Use DisorderAlcohol-associated Liver Disease
Yale University 30
Not applicableActive Not RecruitingNCT06304467
What this trial is testing

CM for Patients With ALD After Liver Transplant

Who this might be right for
Alcohol Use DisorderAlcohol; LiverPost Liver Transplant+2 more
Arpan A. Patel, MD 30
Large-scale testing (Phase 3)Active Not RecruitingNCT02473341
What this trial is testing

Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis

Who this might be right for
Alcoholic Hepatitis
Dayanand Medical College and Hospital 174
Not applicableStudy completedNCT06924281
What this trial is testing

Team Science (The Liver Health Study)

Who this might be right for
Steatotic Liver Disease of Mixed Origin (MetALD)
Brown University 14
Testing effectiveness (Phase 2)Looking for participantsNCT05178069
What this trial is testing

LGG Supplementation in Patients With AUD and ALD

Who this might be right for
Alcohol Use DisorderAlcohol-associated Liver Disease
University of Louisville 60
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableUnknownNCT06403332
What this trial is testing

Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.

Who this might be right for
Alcohol-related Liver DiseaseAlcohol Use DisorderMetabolic and Alcohol Related/Associated Liver Disease+1 more
Hospital Universitari Vall d'Hebron Research Institute 350
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Large-scale testing (Phase 3)Looking for participantsNCT06919458
What this trial is testing

Short Course Steroids in Alcohol Associated Hepatitis

Who this might be right for
Alcoholic Hepatitis
Asian Institute of Gastroenterology, India 146
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Not applicableEnrolling By InvitationNCT06514300
What this trial is testing

Investigating Myosteatosis in Steatotic Liver Diseases

Who this might be right for
Alcohol-related Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver Disease of Mixed Origin (MetALD)+5 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Testing effectiveness (Phase 2)Ended earlyNCT05014087
What this trial is testing

Digoxin In Treatment of Alcohol Associated Hepatitis

Who this might be right for
Acute Alcoholic HepatitisChemical and Drug Induced Liver InjuryAlcohol-Induced Disorders+1 more
Yale University 23
Testing effectiveness (Phase 2)Ended earlyNCT05639543
What this trial is testing

FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study

Who this might be right for
Alcohol Associated Hepatitis
Intercept Pharmaceuticals 67
Testing effectiveness (Phase 2)Looking for participantsNCT07046819
What this trial is testing

Tirzepatide in MetALD

Who this might be right for
Metabolic Alcohol-associated Liver DiseaseAlcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 120
Early research (Phase 1)Looking for participantsNCT04781322
What this trial is testing

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

Who this might be right for
Alcohol Associated Liver DiseaseHeavy Drinking Behavior
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 100
Not applicableNot Yet RecruitingNCT06797596
What this trial is testing

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

Who this might be right for
Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease
Fibronostics USA, Inc 100
Large-scale testing (Phase 3)Study completedNCT02200029
What this trial is testing

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

Who this might be right for
Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
Abbott 75
Not applicableNot Yet RecruitingNCT06763198
What this trial is testing

Genetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis.

Who this might be right for
Alcohol-related Liver Disease
Institute of Liver and Biliary Sciences, India 150
Testing effectiveness (Phase 2)Looking for participantsNCT07009860
What this trial is testing

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Who this might be right for
Alcohol Liver Disease
Altimmune, Inc. 100
Not applicableLooking for participantsNCT06269510
What this trial is testing

Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

Who this might be right for
Alcohol-related Liver DiseaseLiver Diseases
Henry Ford Health System 268
Load More Results